With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging Intuitive Surgical’s da Vinci system.
MedTech Dive
6 days ago
Clinical Trials Arena
J&J MedTech wins IDE for Ottava to greenlight trials for surgical robot
4 days ago
J&J’s nipocalimab shows promise in Phase II Sjögren’s disease trial
3 days ago
Pharmaceutical Technology
FDA grants breakthrough status to J&J’s nipocalimab for SjD treatment
Pharma Voice
Spravato is just the beginning in a new wave of depression meds
7 days ago
BioPharma Dive
TRex Bio raises $84M to compete in crowded immune drug field
5 days ago
View all
